NeuroSense Therapeutics Ltd.
NRSNNasdaqHealthcare · Pharmaceutical Preparations · L3 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 487,264 | 3.6 | -14.6% |
| Apr 30, 2026 | 570,759 | 3.8 | -12.7% |
| Apr 15, 2026 | 653,788 | 5.9 | +10.0% |
| Mar 31, 2026 | 594,593 | 2.5 | +21.3% |
| Mar 13, 2026 | 490,109 | 5.0 | -2.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗- 6-KREPORT OF FOREIGN PRIVATE ISSUERApr 28, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERApr 24, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERApr 6, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERApr 3, 2026
- 4OWNERSHIP DOCUMENTApr 1, 2026
- 3OWNERSHIP DOCUMENTApr 1, 2026
- 3Mar 31, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMar 31, 2026
- 20-FANNUAL REPORTMar 31, 2026
- 4Mar 30, 2026
- 3Mar 30, 2026
- 3Mar 30, 2026
- 4Mar 30, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMar 24, 2026
- 3Mar 18, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.